Paper Details
- Home
- Paper Details
Striatal D2/D3 receptor occupancy, clinical response and side effects with amisulpride: an iodine-123-iodobenzamide SPET study.
Author: BoernerR, DreselS, FrodlT, GründerG, HahnK, MeisenzahlE M, MöllerH-J, ScheuereckerJ, SchmittG, SchwarzM, StaussJ, la FougèreC
Original Abstract of the Article :
INTRODUCTION: Amisulpride appears to be an effective atypical agent for treating schizophrenia in a dose-dependent manner. METHODS: 29 patients suffering from schizophrenia or schizoaffective disorder were treated with a broad dose range of amisulpride (50-1 200 mg/day, mean: 455.2+/-278.8 mg/day)....See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1055/s-2008-1076727
データ提供:米国国立医学図書館(NLM)
Striatal D2/D3 receptor occupancy, clinical response and side effects with amisulpride: an iodine-123-iodobenzamide SPET study
The [neurological] desert is a vast and complex landscape, filled with intricate pathways and delicate balances. This study delves into the [pharmacological effects] of amisulpride, an atypical antipsychotic medication used to treat [schizophrenia], by examining its impact on dopamine receptor occupancy in the brain.Dopamine Receptor Occupancy and Clinical Response
The researchers used [single photon emission computed tomography (SPECT)] to measure the occupancy of [dopamine D2 receptors] in the striatum of patients treated with amisulpride. The study found that amisulpride produced significant [striatal D2 receptor blockade] in a dose-dependent manner, highlighting its ability to target specific brain regions involved in schizophrenia.Clinical Implications
The study's findings suggest that amisulpride, while demonstrating [good efficacy] in treating schizophrenia, also carries a [risk of extrapyramidal side effects]. This underscores the need for careful monitoring and management of side effects in patients treated with this medication.Dr. Camel's Conclusion
This study provides valuable insights into the [pharmacological mechanisms] of amisulpride, revealing its ability to target specific dopamine receptors in the brain and highlighting its potential for treating schizophrenia. The researchers' use of SPECT imaging allows for a detailed examination of the drug's effects on the brain, offering valuable information for clinicians to make informed decisions about treatment options. However, the study also emphasizes the importance of considering the potential for side effects, particularly extrapyramidal symptoms. As Dr. Camel, I am always intrigued by the complex interplay between drugs and the brain, and this study offers valuable insights into the intricate mechanisms underlying amisulpride's therapeutic effects. It is crucial for clinicians to stay informed about the potential benefits and risks of medications to provide the best possible care for their patients.Date :
- Date Completed 2008-12-18
- Date Revised 2018-12-01
Further Info :
Related Literature
Article Analysis
SNS
PICO Info
in preparation
Languages
English
Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.